| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $122.05M | $88.12M | $7.30M | $10.60M | $19.34M |
| R&D | $100.64M | $75.06M | $1.01M | $4.75M | $13.83M |
| SG&A | $21.41M | $13.06M | $6.28M | $5.85M | $5.50M |
| Operating Income | -$122.05M | -$88.12M | -$7.30M | -$10.60M | -$19.34M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | $0.00 | $0.00 | $0.00 |
| Net Income | -$105.43M | -$83.72M | -$5.34M | -$9.93M | -$19.32M |
| EPS (basic) | – | -3.8700 | -0.3700 | -0.6900 | -1.3900 |
| EPS (diluted) | – | -3.8700 | -0.3700 | -0.6900 | -1.3900 |
| Shares (diluted) | – | $16.79M | $14.42M | $14.41M | $13.90M |